Virological Outcomes After Switching to Abacavir/Lamivudine/Dolutegravir Combined with Adherence Support in People Living with HIV with Poor Adherence: A Phase IV, Multicentre Randomized Prospective Open Label Study
Determining if switching from current multi-tablet to single-tablet ART, both combined with individualized adherence support, would improve HIV suppression in non-adherent vulnerable populations
View Publication